Helixmith Co., Ltd (KOSDAQ:084990)

South Korea · Delayed Price · Currency is KRW

3,340.00

+45.00 (1.37%)

Jul 21, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '13 Dec 31, 2013
Pharmaceutical Research and Development Projects, Etc.			8.93B	14.36B	10.57B	18.75B	9.31B
Pharmaceutical Research and Development Projects, Etc. Growth			-37.83%	35.90%	-43.65%	101.53%	-
Consolidation Adjustments			-4.73B	-11.56B	-8.25B	-14.51B	-4.85B
Total			4.20B	2.80B	2.32B	4.25B	4.45B
Total Growth			50.08%	20.87%	-45.48%	-4.63%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '13 Dec 31, 2013
South Korea			3.36B	2.39B	1.95B	3.83B	4.03B
South Korea Growth			40.81%	22.64%	-49.10%	-5.04%	-21.60%
Asia			157.16M	231.41M	59.74M	28.24M	275.67M
Asia Growth			-32.09%	287.35%	111.57%	-89.76%	93.47%
America			681.52M	179.94M	309.12M	450.48M	150.23M
America Growth			278.75%	-41.79%	-31.38%	199.86%	-
Total			4.20B	2.80B	2.32B	4.30B	4.45B
Total Growth			50.08%	20.87%	-46.19%	-3.37%	-15.65%